news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

China Fund News reporter Cao Wenjing

This week (July 22 to July 26), a total of 15 new funds (only main codes are counted) were launched in the market. Among them, active equity funds have become the main force. Obviously, against the background of A-share volatility, fund companies still maintain a positive attitude of deploying equity funds against the market trend.

15 new funds launched

Most equity products

According to the announced fundraising plan, equity products are the focus of various fund companies' layout in the issuance of new public funds this week.

Wind data shows that a total of 7 active equity funds were issued this week, which is the product type with the most public offerings. Among them, 5 are equity-oriented mixed funds and the remaining 2 are stock funds.

These newly issued active equity funds mainly focus on hot themes or industries such as dividends, technology, resources, and medicine. For example, the main feature of the Fuguo Hong Kong Stock Connect Dividend Selection A is to dig for gold in dividends, embrace the core assets of Hong Kong stocks, and select high-quality listed companies with high dividend yields and stable dividends. The proposed fund manager of this product is Ning Jun, the "Hong Kong stock queen" of Fuguo.

The proposed fund manager of Yongying Rong'an A is Gao Nan, Chief Equity Investment Officer and General Manager of Equity Investment Department of Yongying Fund. Gao Nan is optimistic about the overall market outlook. The product will focus on three types of investment opportunities: demand-driven (such as export business, education, publishing, equipment upgrades, etc.), supply-constrained (such as resource stocks, ships, etc.), and cost advantage + industry reversal (such as agriculture, etc.).

Robeco Resource Select A focuses on resource-themed investment. The proposed fund manager of the fund is Huang Daoli, who has 15 years of research experience and is deeply involved in the cyclical materials industry. Dongxing Pharmaceutical Bio-Quantitative Stock Selection A is a bio-pharmaceutical quantitative theme fund that uses fundamental quantitative stock selection to seize opportunities to increase bio-pharmaceutical holdings. The proposed fund manager of this product is Li Weibing, a "quantitative expert" of Dongxing Fund.

In terms of fixed income, among the four bond funds launched this week, there is one secondary bond fund, one bond index fund, and two medium- and long-term pure bond funds. Among them, Hongtu Innovation Tianyi A has a fundraising cap of 8 billion yuan, and Xinhua Zhongzhai 0-3 Year Policy Financial Bond A has a fundraising cap of 6 billion yuan.

Many bond funds are favored by funds

Judging from the establishment of new funds last week (July 15th to July 19th), many bond funds are more popular with funds.

For example, on July 16, China Life Security Taining Interest Rate Bond was established, and the fund raised 5.995 billion yuan. On July 17, Huabao Baojia 30-Day Holding A also issued a fund establishment announcement, and the fund raised 4.810 billion yuan. Both products are medium- and long-term pure bond funds. In addition, a passive index bond fund, Huabao 0-2 Year Government Bond Index A, was also established on July 17, and the fund raised 4.150 billion yuan.

In addition, several ETF products were established last week, including Bosera CSI Dividend Low Volatility 100 Link A, Huatai Zijin CSI Semiconductor Industry Index A, Southern CSI All-Share Power Utilities Link A, Penghua CSI Hong Kong Stock Connect Technology Link A, and Fuguo CSI Central Enterprises Dividend ETF. Among them, Bosera CSI Dividend Low Volatility 100 Link A and Fuguo CSI Central Enterprises Dividend ETF raised funds at the forefront of index funds, at 636 million yuan and 488 million yuan respectively.

Editor: Captain

Review: Muyu

Copyright Notice

"China Fund News" enjoys the copyright to the original content published on this platform. Reproduction without authorization is prohibited, otherwise legal liability will be pursued.

Contact person for authorized reprint cooperation: Mr. Yu (Tel: 0755-82468670)